Introduction {#S1}
============

Adult hippocampal neurogenesis (AHN) is now widely studied in the neuroscience field, because newly born neurons induce large-scale neuronal circuit alterations that are reported to be involved in learning and memory ([@B62]; [@B116]; [@B45]; [@B20]; [@B1]), diseases, such as epilepsy, stroke, and mental disorders ([@B17]; [@B22]; [@B13]; [@B114]), and the regeneration of brain tissue ([@B91]; [@B42]; [@B83]). Such research progress has been achieved mostly in rodents using modern experimental techniques, but has not been accomplished in humans, because the approaches that can be applied to human research are limited.

Adult hippocampal neurogenesis in rodents was discovered in the 1960s by Joseph Altman ([@B4]; [@B6]), but this revolutionary concept had not been fully accepted until the late 1990s ([@B36]; [@B5]; [@B45]; [@B93]). AHN was rediscovered in the early and mid 1990s by the development of new techniques, such as the labeling of newly generated cells by bromodeoxyuridine (BrdU), and immunohistochemistry using an antibody for polysialylated neural cell adhesion molecule (PSA-NCAM) ([@B96], [@B97]; [@B55]).

For demonstrating the existence of human AHN, the BrdU-labeling technique clearly played an important role. [@B23] investigated postmortem hippocampi from cancer patients who received a BrdU infusion for diagnostic purposes, and demonstrated the presence of newly born neuron that are BrdU-labeled cells costained with the neuronal marker NeuN, indicating that neurons are born in the adult human hippocampus.

However, subsequent studies using BrdU in humans have not been performed to date, probably because of the toxicity of BrdU. Instead, many immunohistochemical studies using markers of stem/progenitor cells and immature neuronal markers (INMs) have been performed on the human hippocampus without BrdU labeling, and a large amount of data on human AHN has been accumulated ([@B32]; [@B123]; [@B21]).

In recent years, an important question was raised as to the extent of human AHN, because an immunohistochemical study suggested a sharp decline in neurogenesis during the early postnatal period, and an undetectable level of neurogenesis in the adult human hippocampus ([@B106]), whereas other reports suggest persistent AHN in humans ([@B11]; [@B73]; [@B113]). These studies resulted in many controversial debates ([@B46]; [@B56]; [@B82]; [@B112]; [@B81]; [@B105]), because solving this problem is inevitable when physiological and pathological functions of human AHN are inferred on the basis of data on rodent AHN.

In this article, I will review the studies on AHN in rodents and humans, followed by those in non-human primates to fill the gap between rodents and humans. Furthermore, interpretation of the expression of INMs in these specimens to understand human AHN will also be discussed.

AHN in Rodents {#S2}
==============

During the previous three decades, numerous studies on AHN have been performed in mice and rats. Particularly in mice, modern gene manipulation techniques demonstrated many aspects of AHN, such as the properties of stem/progenitor cells and their developmental processes and regulatory mechanisms, as well as their function in diseases associated with AHN ([@B31]; [@B102]; [@B40]; [@B114]). Therefore, most general knowledge of AHN comes from studies performed in mice.

Properties of Adult Neural Stem Cells {#S2.SS1}
-------------------------------------

To date, many studies on rodents have repeatedly indicated that granule cells are generated in the subgranular zone (SGZ) of the adult hippocampal dentate gyrus (DG), which is the narrow band of cells between the granule cell layer (GCL) and the hilus. The SGZ harbors adult neural stem cells (aNSCs) that express the stem cell markers nestin and Sox2, and demonstrate a radial morphology ([@B54]; [@B26]). Furthermore, aNSCs have astrocytic features, including the expression of astrocyte markers, such as glial fibrillary acidic protein, brain lipid-binding protein, and glutamate-aspartate transporter ([@B104]), but not S100β expression ([@B103]; [@B110]). However, it should be noted that although aNSCs express these molecular markers, not all cells positive for these markers are aNSCs, because astrocytes and non-aNSCs also express these markers ([@B119]; [@B124]).

Neuronal Differentiation of Neural Stem Cells {#S2.SS2}
---------------------------------------------

Adult neural stem cells give rise to neurons via the proliferation of intermediate progenitors or the transient amplification of progenitor cells that can proliferate to self-renew a few times to produce neurons. It has been reported that early proliferating intermediate progenitor cells express Ascl1, Prox1, and Hu, and that late proliferating intermediate progenitor cells express PSA-NCAM, doublecortin (DCX), and NeuroD ([@B101]; [@B119]; [@B48]; [@B124]).

The morphology of neural progenitor cells differs from that of mature granule cells. Neural stem/progenitor cells proliferate and form clusters that contain from a few to more than 10 cells ([@B101]). The neuronal progenitor cells within the clusters are round or ovoid cells with short processes that are smaller than mature granule cells. These neural precursor cells migrate horizontally in the SGZ, to become horizontally oriented fusiform cells extending long horizontal processes ([@B101]; [@B85]). They then settle in their final position, extending their thin apical dendrites.

Maturation of Neuronal Precursor Cells {#S2.SS3}
--------------------------------------

During the maturation process, newly generated neurons expressing INMs develop axons and branched dendrites, form synapses on them, and finally become mature granule cells ([@B39]; [@B98], [@B99]; [@B14]; [@B24]; [@B111]; [@B30]). Developing granule cells initially strongly express PSA-NCAM, and have few synaptic contacts on the cell surface of developing dendrites ([@B99]) and axon terminals ([@B98]). The expression of PSA-NCAM and DCX disappears from half of the newly generated cells by 4--6 weeks after their birth ([@B92]; [@B14]), and the developing granule cells become mature granule cells that have synaptic contacts. Because PSA-NCAM is known to prevent the formation of cell-cell contacts ([@B90]), PSA-NCAM may interfere with synapse formation during dendrite development. The newly generated and developing granule cells are reported to have high excitability ([@B19]; [@B66]), but the excitability decreases by 8 weeks after generation ([@B72]).

Aging and AHN {#S2.SS4}
-------------

Many reports demonstrate that the level of rodent AHN declines with age ([@B97]; [@B8]; [@B9]; [@B58]). The number of proliferating (Ki67+, PCNA+) cells, INM+ (DCX+, PSA-NCAM+) cells, and BrdU-labeled cells positive for neuronal markers are exponentially decreased during 2--6 months of age in rodents. However, thereafter, a small number of these cells persist during aging, and can be detected even in aged rodents, suggesting that rodent AHN occurs throughout life, but the level of AHN is low in middle-aged rodents.

AHN in Humans {#S3}
=============

Early Studies in the 1990s {#S3.SS1}
--------------------------

The first suggestion of postnatal human neurogenesis was from a study in 1994, in which immunohistochemical staining was performed for PSA-NCAM in the structurally non-atrophic brains of children with extrahippocampal seizures. The study showed that in children with severe epilepsy, numerous PSA-NCAM+ immature neurons exist in the SGZ and GCL of the hippocampus of children younger than 2 years of age, but such neurons decrease in number by 6--8 years of age, and are undetectable in older children (\>8 years of age) ([@B67], [@B68]).

However, another study in 1998 that performed PSA-NCAM immunohistochemistry on surgically removed hippocampi and entorhinal cortices of patients with drug-refractory temporal lobe epilepsy (mean age, 34 years) and autopsy controls (mean age, 47 years) demonstrated that a substantial number of PSA-NCAM+ cells are detectable in the SGZ of the adult human hippocampus, and that the number decreases in epileptic patients with severe neuronal damage ([@B70]). Similarly, another study reported that PSA-NCAM+ cells were found in patients with Alzheimer disease (mean age, 82 years) and control patients (mean age, 71 years) ([@B71]).

A study of postmortem human brains at the age of 7 months to 82 years with no obvious neuropathology demonstrated that strongly PSA-NCAM+ immature granule cells extending mossy fibers are found in the SGZ and GCL by 3 years of age ([@B79]). After that, the number of PSA-NCAM+ cells decreased substantially, but numerous PSA-NCAM+ hilar neurons appeared at 2--3 years of age and persisted until the eighth decade of life. Although the exact reasons as to why the above three studies are inconsistent regarding the presence or amount of PSA-NCAM+ cells in adults remain unclear, it may be owing to differences in patients (with or without epilepsy), the severity of their seizures, sample conditions (postmortem brains or surgically removed hippocampi), and immunohistochemical methods.

A unique study of postmortem brains from adult cancer patients (average age: 64.4 ± 2.9 years) injected with BrdU for estimating the proliferation of tumor cells identified newly generated neurons in the adult human hippocampus, which had BrdU-labeled nuclei with NeuN+, calbindin+, and neuron specific enolase+ cell bodies ([@B23]). However, the extent of AHN, as reported in rodent quantitative fate-mapping experiments, remained unclear.

Studies Between 2000 and 2017 {#S3.SS2}
-----------------------------

As the use of BrdU is difficult in humans owing to its toxicity, for the detection of stem cells, proliferating cells, neural progenitors, and immature neurons in the human hippocampus, many researchers have performed immunohistochemistry for several molecular markers of proliferating cells, stem/progenitor cells, and immature neurons, which suggested the presence of AHN in the brains of healthy humans ([@B50]; [@B18]; [@B69]) and patients with epilepsy ([@B61]), ischemia ([@B44]; [@B64]), Alzheimer disease ([@B43]; [@B60]), and psychiatric diseases ([@B21]). Some studies have shown distinct age-dependent alterations in AHN.

An immunohistochemical study on postmortem human brains from birth to 100 years of age demonstrated that DCX+ cells are present in the SGZ and GCL during aging, but the number of DCX+ cells declines exponentially, and becomes very low by 2 years of age, and furthermore, that during aging, the appearance of DCX+ cells changes; i.e., at younger ages, DCX immunoreactivity is seen in apical dendrites, but at older ages, it is distributed only around the nucleus, suggesting that the expression pattern of DCX in the hippocampal neurogenic region is altered qualitatively and quantitatively with aging ([@B50]).

Immunohistochemistry of Ki67 and DCX in the postmortem brains of subjects between the age of 0.2 and 59 years has shown that in infants, DCX+ cells are densely clustered in the GCL, but Ki67+ proliferating cells are distributed throughout the DG ([@B18]). Thereafter, the number of clusters of DCX+ cells became very low by 3 years of age, and only a sparse distribution of DCX+ cells was seen in older juveniles and adults. Ki67+ proliferating cells were rarely seen in the SGZ. In addition, it has been reported that the mRNA levels of Ki67 and DCX in the healthy human hippocampus decreases throughout the lifespan of a human ([@B69]). These data suggest that human AHN sharply decreases in infants.

New Techniques in the 2000s {#S3.SS3}
---------------------------

In addition to immunohistochemical techniques, nuclear magnetic resonance spectroscopy is used for non-invasively detecting biomarkers that are enriched in neural stem cells and neural progenitor cells in the live human brain, and has the possibility of identifying and quantifying adult human neural stem cells and progenitor cells ([@B10]; [@B65]; [@B15]).

Attention has also been paid to new alternative approaches to estimate the levels of neurogenesis in humans, by measuring the concentration of nuclear bomb test-derived ^14^C in genomic DNA. Analysis using this method suggested that in adult humans, 700 new neurons are added to the hippocampus every day, and a large subpopulation of hippocampal neurons is exchanged throughout life, suggesting that humans and mice have similar levels of AHN ([@B108]). The ^14^C birth dating method also showed the existence of neurogenesis in the adult striatum, and its absence in the adult human neocortex ([@B10]).

Recent Conflicting Reports in 2018 and 2019 {#S3.SS4}
-------------------------------------------

A recent study of postmortem brains from human fetal and postnatal subjects, and surgically resected samples from epileptic patients showed that the number of Ki67+/Sox2+ proliferating progenitors and DCX+/PSA-NCAM+ young neurons in the DG decrease sharply during the first year of life, and that neurogenesis in adults is undetectable ([@B106]). This study caused considerable debate ([@B46]; [@B56]; [@B82]; [@B112]; [@B105]).

Soon after the above study, a study on hippocampi collected on autopsy demonstrated the persistence of proliferating neuronal progenitors and immature neurons, despite a decrease in the number of quiescent stem cells ([@B11]). An immunohistochemical study using improved tissue processing methods showed that AHN occurs frequently ([@B73]). These improved immunohistochemical techniques revealed a substantial number of DCX+ cells in the human DG. A subpopulation of DCX+ cells were positive for PH3, Prox1, PSA-NCAM, calbindin, and calretinin, but they were often found in the upper and middle parts of the GCL in addition to the SGZ, which appears to resemble granule cells undergoing dematuration, as reported previously ([@B38]; [@B80]). Persistent neurogenesis, which is shown by the presence of Nestin+/Sox2+/Ki67+ neural progenitors, DCX+/PCNA+ neuroblasts, and DCX+ immature neurons, was also reported in older adults and to a lesser extent, in Alzheimer disease patients ([@B113]).

A part of the discrepancy in immunohistochemical studies appears to be caused by differences in techniques and specimens ([@B73]). Most specimens were derived from postmortem brains with different postmortem intervals until fixation, as well as different methods of surgical removal of tissue. Regarding immunohistochemistry, there are differences in the methods of tissue preparation among the samples (paraffin or cryostat sections), and immunohistochemical procedures varied among the studies (with/without antigen retrieval pretreatment).

In this regard, a recent study using specimens surgically removed and immediately fixed, and subjected to antigen retrieval treatments clearly showed that a substantial number of PSA-NCAM+ neurons are distributed densely below the GCL, but the number of proliferating progenitors (Ki67+/HuB+/DCX+ cells) were very low ([@B100]). This suggests that immature-type neurons are not recently generated neurons, and the level of hippocampal neuronal production in adult humans is low. This conclusion raises the question as to the identity of INM+ cells, which will be discussed later.

AHN in Non-Human Primates {#S4}
=========================

Knowledge regarding AHN in non-human primates is expected to bridge the gap between humans and rodents ([@B120]; [@B16]), because (1) analysis of exact cell division, and fate tracing using BrdU can be performed, (2) non-human primates are evolutionally the most close relatives of humans, and (3) some non-human primate species have a much longer lifespan than rodents. The following information of the ages of their first reproduction and the lifespan of non-human primates was obtained from previous studies ([@B33]; [@B7]).

In the late 1990s, the occurrence of AHN in non-human primates was demonstrated in some types of monkeys using BrdU labeling and markers for proliferating cells (PCNA), mature neurons (neuron-specific enolase, NeuN), and immature neurons (TuJ1, TOAD-64). The first indication of AHN in an animal close to primates was from treeshrews (*Tupaia belangeri*) at the age of 7 months to 2.5 years (age at first reproduction = 4--5 months, lifespan = up to 12 years in captivity) ([@B33]). After that, the presence of AHN in non-human primates was reported in common marmoset monkeys (*Callithrix jacchus*) at the age of 3 years (age at first reproduction = 595 days, average lifespan = 12 years) ([@B35]), and macaque monkeys (*Macaca mulatta* and *Macaca fasciculata*) at the age of 5.5--16.5 years ([@B53]) and at the age of 5--23 years ([@B34]), respectively (*M. mulatta*, age at first reproduction = 1,279 days, average lifespan = 14 years; *Macaca fascicularis*, age at first reproduction = 1,410 days, average lifespan = 14 years).

In the 2000s, several reports on non-human primates indicated that the AHN is affected by stress ([@B35]), antidepressants ([@B84]), and ischemia ([@B115]; [@B121]; [@B52]). Non-human primate AHN may also be involved in memory and learning ([@B3]), but AHN and learning ability are reported to be moderately associated with each other ([@B76]).

Absolute, but Not Relative, Age-Dependent Decrease in Neuronal Production {#S4.SS1}
-------------------------------------------------------------------------

An early study in macaque monkeys showed that although neuronal production was found in both young and aged monkeys, the numbers of BrdU-labeled proliferating cells and TOAD-64-expressing immature neurons were much lower in aged monkeys than in young monkeys ([@B34]). Thereafter, detailed quantitative studies repeatedly confirmed the age-associated exponential decline in adult non-human primate neurogenesis in common marmosets ([@B59]) and macaque monkeys ([@B3], [@B2]; [@B7]; [@B76]).

Comparison of the age-dependent decrease in neurogenesis between rodents and non-human primates has demonstrated an important hypothetical concept that the decrease in neurogenesis, particularly proliferation of progenitor cells, is regulated by absolute age, but not by relative age ([@B53]; [@B7]). There is a considerable difference in lifespan between rodents and non-human primates, i.e., the lifespan of mice and rats is 1.5--2.5 years, whereas the lifespan of rhesus monkeys (*M. mulatta*) is 14 years. Nevertheless, in both rodents and monkeys, the numbers of proliferating cells are exponentially reduced by 2--3 years of age, although at 2 years of age, rodents are aged animals, but rhesus monkeys are infants. Thus, a decrease in postnatal neurogenesis occurs in rodents at middle to older stages, but in macaque monkeys at infant stages.

Prolonged Maturation of Newly Generated Neurons in Non-human Primates {#S4.SS2}
---------------------------------------------------------------------

The detailed developmental processes of the generation of new neurons in rhesus monkeys have been reported ([@B77], [@B78], [@B76]; [@B51]). An important phenomenon in non-human primates is the prolonged time required for the maturation of newly generated granule cells compared with rodents. The period required for maturation was estimated using the time when the expression of INMs, i.e., PSA-NCAM and DCX, disappears from BrdU-labeled newly generated cells.

In rodents, most new BrdU-labeled neurons lost PSA-NCAM and DCX immunoreactivity by 1--1.5 months after BrdU injection, indicating that the maturation of newly born granule cells occurs by 1--1.5 months ([@B92]; [@B14]; [@B47]). However, in the case of adult macaque monkeys, only half of the BrdU-labeled newly generated neurons lost their DCX expression by 6 months, and during this time period, new neurons continued to develop their dendrites, suggesting that maturation of new granule cells at the structural and molecular levels takes more than 6 months ([@B51]; [@B76]). This suggests that newly generated neurons in non-human primates have substantial plasticity during a long period. This prolonged immature state may compensate for the decrease in plasticity caused by a rapid decrease in neurogenesis in non-human primates.

Furthermore, a recent report has shown that an increase in DCX+ dentate granule cells without an increase in neuronal production is induced by fluoxetine treatment in the common marmoset, which suggests that mature granule cells are able to re-express INMs, which is a phenomenon called dematuration ([@B80]).

Validity of INMS as Proxy Markers for Adult Neurogenesis {#S5}
========================================================

Not all PSA-NCAM and DCX-expressing neurons are newly generated neurons in the adult brain. The existence of PSA-NCAM+ and DCX+ neurons in non-neurogenic regions of the adult brain has been reported in various mammals, including rodents, non-human primates, and humans ([@B57]). BrdU-labeling studies clearly demonstrated that the INM+ neurons in non-neurogenic regions are generated during the embryonic periods ([@B29]; [@B63]; [@B89]).

In adult mice, rats, guinea pigs, and rabbits, PSA-NCAM+ and DCX+ cells are found in the paleocortex (piriform and entorhinal cortices) ([@B94]; [@B12]; [@B75]; [@B29]; [@B49]), cingulate cortex ([@B28]), association cortex ([@B63]), and spinal cord ([@B95]). Additionally, it was also reported that even in the hippocampus, PSA-NCAM+ neurons are seen in non-neurogenic regions, such as the hilus, CA1/3, and subiculum ([@B74]). These accumulated data indicate that PSA-NCAM+ and DCX+ cells in these non-neurogenic regions consist of a subpopulation of interneurons, and have immature characteristics in their structures, including less dendritic arborization, spine density, and synaptic contacts ([@B29], [@B28]; [@B37]). A recent fate-mapping study using DCX-CreER^T2^/Flox-EGFP transgenic mice demonstrated that DCX+ neurons in the adult piriform cortex progressively resume the development of dendrites, axons, and synaptic contacts during aging ([@B57]).

INM+ cells in non-neurogenic regions are also observed in mammals with a large brain and long lifespan. In adult sheep, a study using INMs and BrdU labeling demonstrated that DCX+ cells are present in the external capsule and the surrounding gray matter (claustrum and amygdala), in addition to the piriform cortex and neocortex ([@B86]). In non-human primates, DCX+ neurons are found in non-neurogenic regions, such as the amygdala, entorhinal cortex, inferior temporal gyrus, and medial orbital gyrus ([@B125]). DCX+ neurons generally coexpress PSA-NCAM, and some of them express neuron-specific nuclear protein and γ-aminobutyric acid, suggesting that they contain interneurons. Furthermore, similarly to INM+ cells in the neurogenic region, these cells demonstrate an age-dependent decrease in number. It has been proposed that mammals with a large brain and long lifespan have more INM+ non-newly generated neurons than mammals with a small brain and short lifespan ([@B57]).

In humans, DCX+ and PSA-NCAM+ cells have been identified in non-neurogenic regions of the neocortex ([@B117]; [@B109]), amygdala ([@B107]), and brain stem ([@B122]). Furthermore, PSA-NCAM+ cells have been found in the non-neurogenic regions of the hippocampal formation, such as the CA1/3, subiculum, and entorhinal cortex ([@B70], [@B71]; [@B100]).

Although the exact nature and function of these INM+ cells in non-neurogenic regions remain unclear, some interesting hypotheses have been proposed, for example, the cells are in a state of arrested development ([@B27]), in the process of continuous maturation of dormant precursors ([@B88]), and are a reservoir of young cells for the adult/aging brain ([@B57]).

Doublecortin and PSA-NCAM are generally used as proxy markers for AHN, but they should be considered as markers indicating immaturity or plasticity among both newly generated neurons and non-newly generated neurons. DCX, a microtubule-associated protein that is involved in the extension of neuronal processes, and PSA-NCAM, a cell-surface molecule that is implicated in cell movement and recognition of the cell surface, may be required for structural changes of both newly generated and non-newly generated neurons. Therefore, it should be noted that the level of neuronal production and neurogenesis cannot be evaluated solely by immunohistochemistry for INMs, and also that DCX, as well as PSA-NCAM, are not faultless molecular markers in terms of detecting newly or recently generated neurons ([@B118]).

The Real State of Human AHN {#S6}
===========================

What do the studies on rodent and non-human primate AHN tell us about the real state of human AHN? These studies show the following: (1) proliferation of neural progenitor cells to produce new granule neurons in the SGZ of the hippocampus is decreased with absolute age, but not with relative age, which suggests that neuronal production in the human SGZ is also decreased with absolute age, as in non-human primates, (2) the maturation period of newly generated granule cells is much longer in primates than in rodents, which suggests that newly generated dentate granule cells in humans have a longer maturation period than those in rodents, and possibly than those in non-human primates, (3) INM+ cells in non-newly generated cells are detected in several adult brain regions of several mammalian species, which suggests the possible existence of similar immature-type neurons in the human hilus, SGZ, and GCL, in addition to INM+ adult-born or recently generated granule cells.

Although there are conflicting conclusions on human AHN, there is some agreement, as follows: (1) postnatal neuronal production in the SGZ occurs at a substantial level up to a few years after birth, but declines sharply, and (2) a substantial number of INM-expressing neurons exist in the adult human SGZ, although the detection of DCX+ cells depends on immunohistochemical methods, particularly antigen retrieval procedures ([Figure 1A](#F1){ref-type="fig"}).

![A new hypothetical model of the real state of human adult hippocampal neurogenesis. **(A)** Changes in the levels of neuronal production, immature neuronal marker-positive (INM+) newly generated neurons, and INM+ neurons in the adult human SGZ during aging. **(B)** The origin of INM+ neurons in the adult human hippocampus. NP, proliferating neural progenitor cells.](fnins-14-00839-g001){#F1}

With the cumulative knowledge from rodents, non-human primates, and humans, as well as the data from our recent study in humans ([@B100]), I have developed a hypothesis about the real state of human AHN ([Figure 1](#F1){ref-type="fig"}). In humans, there are at least two stages of postnatal hippocampal neurogenesis, i.e., the infant stage with a substantial level of neuronal production, and the adult stage with a very low level of neuronal production and a substantial number of INM-expressing cells, although the exact change in the number of INM+ cells during infant to adult stages is unknown. Additionally, regarding the origin of INM-expressing cells in the SGZ of the adult human hippocampus, there are three possible origins. The INM-expressing neurons are derived from (1) neurons with prolonged INM expression that are generated by adult neural progenitor cells and continue to express INMs over a prolonged period of time, (2) INM-expressing arrested neurons that are produced by embryonic neural progenitor cells and maintain immaturity, such as INM expression, and (3) INM-re-expressing neurons that are converted from mature or INM-negative adult neurons that are generated during the embryonic period ([Figure 1B](#F1){ref-type="fig"}). Even though INM-expressing cells in the human adult hippocampus have different origins, they may have similar plasticity and compensate for the decline in plasticity by a low level of neurogenesis.

Application of Rodent Studies to Understand Human "Postnatal" Hippocampal Neurogenesis {#S7}
======================================================================================

Next, I would like to propose some possible roles of "infant" and "adult" human hippocampal neurogenesis. In other words, there are possible ways to apply the vast accumulating knowledge about rodent AHN to understanding the functions of human AHN. Are learning and memory functions associated with postnatal neurogenesis in humans? An important point in postnatal neurogenesis is that new neurons are born and develop under circumstances in which various environmental sensory stimuli and locomotion information are inputted into hippocampal neuronal circuits ([@B62]). This is very different from the condition of prenatal neurogenesis, which is not affected in principle by these inputs. In this sense, there is no difference between AHN in rodents and early postnatal neurogenesis in humans. Even though hippocampal neuronal production is limited to the early postnatal period in humans, studies on adult rodent neurogenesis are still worth performing to understand neurogenesis-associated learning and memory mechanisms in humans during the early postnatal period, when infants receive various sensory inputs every day and learn effectively from their experiences. Another possibility is that even if a very small number of neurons are newly generated in the adult human hippocampus, the accumulation of these new neurons, which have prolonged expression of INMs, must play important roles in memory and learning.

Do diseases affect postnatal neurogenesis in humans? Epilepsy is well known to be induced more frequently in children than in adults in humans ([@B41]; [@B87]). Epileptic seizures should cause abnormal structural changes in newly generated neurons in infants and children, as in adult rodents, and subsequently must induce serious brain damage in the adult human hippocampus. Even if most PSA-NCAM+ and DCX+ cells in the adult human hippocampus are not recently generated neurons, these neurons that have higher plasticity than mature neurons can be easily altered structurally and physiologically by an epileptic state. In fact, in both epileptic patients and epileptic model rodents, the abnormal structure of PSA-NCAM+ neurons are very similar to each other ([@B100]). Furthermore, some diseases, such as Alzheimer disease ([@B113]) and epilepsy ([@B100]), are reported to show a decrease in the number of INM+ neurons, regardless of whether the INM+ cells are recently generated neurons or non-recently generated neurons.

Taken together, studies on AHN are entering a new era, in which knowledge of rodent studies are not simply applied to understand human AHN, but species differences in brain size, lifespan, and ways of life, and identity of INM-expressing cells must be considered to understand the true state and function of human AHN ([@B7]; [@B25]; [@B57]; [@B81]; [@B100]; [@B105]). Furthermore, comprehensive analyses of postnatally born neurons, both in infants and in adults, and INM-expressing neurons, regardless of their origin, will enable us to understand the state and function of human AHN and plasticity.
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